|
Home : Unsafe Drugs : Avandia : Newsfeeds : VictozaR Meta-analysis Shows Greater Blood Sugar Control At All Baseline A1C Levels When Compared To Other Therapies VictozaR Meta-analysis Shows Greater Blood Sugar Control At All Baseline A1C Levels When Compared To Other Therapies
VictozaR (liraglutide [rDNA origin] injection) 1.8 mg was compared with exenatide, insulin glargine, glimepiride, rosiglitazone, and sitagliptin. Baseline A1C categories included =7.5%, >7.5-8.0%, >8.0-8.5%, >8.5-9.0%, >9.0%. Logistic regression was also ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




